抑肽酶

yì tài méi
  • aprotinin;trasylol
抑肽酶抑肽酶
  1. 结论用抑肽酶行脾动脉灌注、明胶海绵栓塞是治疗脾破裂Gall分级Ⅰ~Ⅲ级可靠而有效的方法;

    Conclusions Trasylol perfusion and gelatin sponge embolization of the splenic artery is a reliable and effective way for treatment of splenic rupture with Gall grades of ⅰ to ⅲ .

  2. 本实验观察了国产加贝酯对大鼠实验性急性胰腺炎的治疗效果,并与进口药品FOY及抑肽酶作了比较。

    The effects of Gabexate mesilate made in China in the treatment of acute experimental pancreatitis was observed , and was compared with that of FOY and Trasylol in the rats with acute pancreatitis .

  3. 结果:抑肽酶组较对照组术后失血和血制品的使用明显减少(P<0.01)。

    Results : In patients given aprotinin , postoperative blood loss and use of blood products were significantly low ( P < 0.01 ) .

  4. 方法取30只雄性新西兰家兔,随机分成三组:对照组(C组)、抑肽酶组(A组)和乌司他丁组(U组),建立兔在体肾脏缺血再灌注损伤模型。

    Methods 30 rabbits were randomly divided into control group , aprotinin group and ulinastatin group respectively , and rabbit ischemia-reperfusion injury model was established .

  5. 选择健康献血员及心内直视手术病人,观察抑肽酶对全血活化凝血时间(ACT)的影响。

    E selected healthy volunteers and patients undergoing cardiopulmonary bypass ( CPB ) to evaluate the effects of aprotinin on the activated clotting time ( ACT ) .

  6. 抑肽酶对常温体外循环中TNF-α、IL-6及IL-8的影响

    Effects of aprotinin on expression of TNF - α, IL-6 , and IL-8 after warm cardiopulmonary bypass

  7. 抑肽酶对围术期急性失血性休克DIC转归的保护作用

    Protection of Aprotinin on perioperative DIC following acute hemorrhagic shock

  8. 抑肽酶对心瓣膜置换术患者围术期IL-6、IL-8释放的影响

    Effect of Aprotinin on IL-6 and IL-8 in the Serum of Patients with Cardiac Valve Replacement During Perioperative Period

  9. 抑肽酶对体外循环中性粒细胞CD(11b)表达的研究

    Effect of Aprotinin on CD_ ( 11b ) Expression of Neutrophilic Granulocytes in Cardiopulmonary Bypass

  10. 抑肽酶抑制中性粒细胞对TNFα活化的人脐静脉内皮细胞黏附和迁移的实验研究

    The Effect of Aprotinin on Polymorphonuclear Neutrophils ( PMN ) Adhesion and Transmigration Through TNF α Activated Human Umbilicus Vein Endothelial Cells in Vitro

  11. 目的:探讨抑肽酶和肿瘤坏死因子α(TNFα)抗体对大鼠肝缺血再灌注损伤的保护作用。

    Objective : To study the protective effects of aprotinin and tumor necrosis factor α( TNF α) antibody on liver ischemia reperfusion injury in rats .

  12. 肾脏显象剂&~(99m)Tc-(Sn)-抑肽酶的制备及动物实验

    A renal imaging agent ~ ( 99m ) tc ( sn ) aprotinin and its preparation and animal experiments

  13. 结论:含抑肽酶的肺保护液对肺的保护效果确切,其保护作用明显优于单纯LPD液。

    Aprotinin contained lung preservation solution is superior to LPD for lung protection .

  14. 目的探讨小剂量抑肽酶对体外循环(CPB)下心脏手术术后出血的影响。

    Objective : To study the effect of low dose aprotinin on postoperative blood loss of cardiosurgery after cardiopulmonary bypass ( CPB ) .

  15. 研究目的:观察小剂量抑肽酶及甲基强的松龙对体外循环(CPB)炎性反应的影响。

    Objective : To observe the effects of low-dose aprotinin and methylprednisolone on the inflammatory response induced by cardiopulmonary bypass ( CPB ) .

  16. 大剂量抑肽酶组:CPB前静给抑肽酶200万KIU,随后持续静滴50万KIU/h至关胸结束,预充液中加入200万KIU。

    High - dose aprotinin group .

  17. 心脏手术中小剂量抑肽酶对中性粒细胞CD(11b)/CD(18)表达的影响

    The effect of low-dose aprotinin on the expression of neutrophil CD_ ( 11b ) / CD_ ( 18 ) in open heart surgery

  18. 应用抑肽酶阻断纤溶酶活性后能够完全阻断proMMP2与proMMP9的活化。

    Inhibiting the activity of plasmin by aprotinin could totally block the conversion of pro-MMP-2 / 9 to active enzyme .

  19. 目的观察体外循环(CPB)心脏瓣膜置换手术中使用大剂量抑肽酶对心肌的保护作用。

    Objective To investigate the myocardial protective effects of large dose of aprotinin on myocardium during cardiac valvular replacement operation under cardiopulmonary bypass ( CPB ) .

  20. 目的观察小儿体外循环术中、术后细胞因子肿瘤坏死因子(TNF)α、白细胞介素(IL)6、IL8的变化,评价抑肽酶对体外循环炎性反应的抑制作用。

    Objective : To evaluated the inhibitory effects of aprotinin on plasma TNF α, IL 6 , IL 8 during and after cardiopulmonary bypass in children .

  21. 抑肽酶可抑制TNFα活化的人脐静脉内皮细胞ICAM-1的表达,可避免β-catenin的丢失。

    Aprotinin could downgrade the expression of ICAM-1 of TNF α activating endothelial cells and prevent the loss of β - catenin of the cells , protect the adherens junctions of endothelials cells .

  22. 目的研究乌司他丁和抑肽酶对体外循环(CPB)小儿炎性反应及心肌损伤的影响。

    Objective To investigate the effects of two protease inhibitors ( ulinastatin and aprotinin ) on inflammatory response and myocardial injury in children undergoing cardiopulmonary bypass ( CPB ) .

  23. 开放60min时抑肽酶组IL-8浓度与开放30min相比无继续升高的趋势(P>005),而对照组仍继续升高(P<005)。

    IL-8 in the aprotinin group at 60 minutes did not increase , compared with that at 30 minutes after reperfusion .

  24. 再灌注24h和48h后,抑肽酶处理组的神经功能评分均显著高于缺血组(P<0.05);

    The neurological function score in aprotinin treatment group was significantly higher than that in ischemia group at 24 hours and 48 hours after reperfusion ( P < 0.05 ) .

  25. 抑肽酶能够显著的降低AQP4表达水平、脑水含量、IL-8含量的水平。

    The level of brain water content 、 IL-8 content 、 AQP4 immune expression intensity was decreased and ion content disorder was improved after Aprotinin administration .

  26. α-抗胰蛋白酶组和抑肽酶组的抑制效果虽不及前两组,但分别较对照组减少了20.04%和18.67%(P0.05)。

    The inhibition effect of α - antitrypsin group and the aprotinin group is not the same as former two groups and compared with the control group , the concentration still respectively reduced 20.04 % and 18.67 % ( P0.05 ) .

  27. 结果再灌注后UTI组动脉血和肺组织中MDA水平、MPO活性较抑肽酶组及对照组低(P<0.05),血清SOD活性较抑肽酶组及对照组高(P<0.05和P<0.01)。

    Results The levels of MDA , MPO in sera of venous blood and lung tissue in UTI group were significantly lower than those in aprotinin group and control group ( P < 0.05 ) .

  28. 抑肽酶使CPB中ACT略延长,与对照组相比无统计学意义,对肝素用量无影响,24小时胸液减少35%(P<0.05)。

    In the aprotinin group , ACT was slightly prolonged but both ACT and heparin requirements showed no significant differences than the control group . The first 24 hour chest tube drainage was reduced 35 % ( P < 0.05 ) than the control group .

  29. 抑肽酶总量成人为400万kIU,儿童为200万kIU。止血芳酸用量为40mg/kg;

    To used aprotinin ( 4 000 000 kIU in adult , 2 000 000 kIU in children ) and tranexamic ( total 40 mg / kg );

  30. 缺血30min时缺血组波形消失,抑肽酶处理组波幅降下30%。

    The waves of ischemia group disappeared at 30 minutes of ischemia , and the waves of aprotinin treatment group reduced to 30 % .